Abstract #3379

Predicting Malignancy in High-Risk Breast Cancer Patients: Evaluating Diagnostic Accuracy of Pre-Treatment Contrast-Enhanced MRI

Yousef Mazaheri¹, Charles W. Fry², Sandra B. Brennan², Elizabeth A. Morris²

¹Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States; ²Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States

To evaluate three empirical parametric models of enhancement (Liner-slope model, Ricker model, and Gamma-variate model) fitted to normalized contrast-enhanced magnetic resonance imaging (CE-MRI) data to better stratify risk in high-risk breast cancer patients.